508 related articles for article (PubMed ID: 27565569)
1. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
3. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
5. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
[TBL] [Abstract][Full Text] [Related]
6. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.
Senapati R; Nayak B; Kar SK; Dwibedi B
BMC Infect Dis; 2017 Jan; 17(1):30. PubMed ID: 28056826
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
9. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
10. HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination.
Wang J; Tang D; Wang K; Wang J; Zhang Z; Chen Y; Zhang X; Ma C
BMC Womens Health; 2019 Jul; 19(1):90. PubMed ID: 31286939
[TBL] [Abstract][Full Text] [Related]
11. Pre-vaccination prevalence and genotype distribution of human papillomavirus infection among women from urban Tunis: a cross-sectional study.
Guettiti H; Ennaifer E; Attia L; Chelly D; Alaya NB; Aissa RB; Laassili T; Boubaker S
Asian Pac J Cancer Prev; 2014; 15(21):9361-5. PubMed ID: 25422225
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia.
Ardhaoui M; Ennaifer E; Letaief H; Salsabil R; Lassili T; Chahed K; Bougatef S; Bahrini A; El Fehri E; Ouerhani K; Paez Jimenez A; Guizani I; Boubaker MS; Ben Alaya NB
PLoS One; 2016; 11(6):e0157432. PubMed ID: 27299955
[TBL] [Abstract][Full Text] [Related]
16. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
[TBL] [Abstract][Full Text] [Related]
17. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
[TBL] [Abstract][Full Text] [Related]
18. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
[TBL] [Abstract][Full Text] [Related]
19. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
Tay SK; Oon LL
Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
